Abstract / Summary
Objective (s): Quality of life is an important health-related outcome measure. This study aimed to assess quality of life in a sample of male patients with premature coronary artery disease (PCAD) and examine its relationship with blood pressure (BP) and lipoproteins (LDL and HDL). Methods: A convenience sample of 240 male patients with confirmed premature coronary artery disease was recruited and were entered into the study. In addition to demographic information, systolic, and diastolic blood pressure, LDL and HDL values were extracted from case records. Quality of life was measured using the SF-12 version 2. Descriptive analysis was performed to analyze the data. Results: The mean (SD) age of participants was 43.29 (*.74) years. The mean (SD) of the physical quality of life component summary score (PCS) was 46.25 (10.26) and it was 49.29 (11.29) for the mental quality of life component summary score. The findings showed that higher LDL values were significantly influenced quality of life in both dimensions while, although in the expected directions, blood pressure categories and LDH did not show statistically significant associations. Conclusion: The findings suggest higher values of LDL could significantly harm quality of life in male patients suffering from premature coronary artery disease. Preventive measures is recommended to improve quality of life in this population.
Topics
Primary Source
Payesh
Ask Prognia AI
Have questions about this review article?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.
Related Clinical Guidelines
Related Blog Posts
ESC 2023 Heart Failure Guidelines: What Every Cardiologist Needs to Know
The 2023 focused update to the ESC Heart Failure Guidelines introduced key changes to SGLT2 inhibitor recommendations, HFmrEF management, and device therapy thresholds. Here is a practical summary.
CHADS₂-VASc in Practice: When to Start Anticoagulation in AF
A practical walkthrough of the CHADS₂-VASc scoring system, its ESC guideline thresholds, and how to use it alongside HAS-BLED to counsel patients with atrial fibrillation.